Valiant Organics Ltd

Valiant Organics Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Valiant Organics Ltd

₹ 328 -0.48%
22 Nov - close price
valiantorganics.com BSE: 540145 NSE: VALIANTORG
About

Incorporated in 1984, Valiant Organics
Ltd manufactures and deals in specialty chemicals and pharma intermediates[1]

Key Points

Business Overview:[1][2][3]
VOL is is promoted by Gogri, Chedda and Gala families. It is a manufacturer and seller of specialty chemicals. It is one of the largest manufacturers of chlorophenol derivatives, Benzene derivatives, PNA, PAP, Ortho Anisidine and Para Anisidine. Company has a client base across Pharmaceuticals, Dyes & Pigments, Agrochemicals, specialty chemicals, and veterinary medications

Website BSE NSE
  • Market Cap ₹ 906 Cr.
  • Current Price ₹ 328
  • High / Low ₹ 519 / 307
  • Stock P/E
  • Book Value ₹ 237
  • Dividend Yield 0.00 %
  • ROCE 0.96 %
  • ROE -1.14 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 2.26% over past five years.
  • Company has a low return on equity of 8.94% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE Allcap BSE Commodities BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
213 261 291 235 232 218 227 177 182 141 177 168 160
176 216 246 208 201 189 183 156 165 138 179 152 158
Operating Profit 37 45 44 26 31 28 44 20 17 4 -2 16 2
OPM % 17% 17% 15% 11% 14% 13% 19% 11% 9% 3% -1% 9% 1%
0 2 1 1 0 6 1 6 0 0 2 0 2
Interest 2 1 2 3 2 3 3 4 4 4 7 5 8
Depreciation 6 8 7 6 7 7 8 8 8 9 9 9 9
Profit before tax 29 37 36 18 23 24 34 14 5 -9 -16 2 -13
Tax % 27% 26% 25% 24% 25% 24% 24% 25% 26% -22% -32% 118% -12%
22 28 27 14 17 19 26 10 4 -7 -11 -0 -11
EPS in Rs 7.92 10.16 10.01 5.08 6.29 6.82 9.65 3.82 1.44 -2.43 -3.86 -0.16 -4.04
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
34 43 59 52 73 121 606 584 574 948 912 677 646
28 34 48 36 55 94 426 410 417 783 782 638 626
Operating Profit 6 8 11 16 18 26 179 174 157 165 130 40 20
OPM % 18% 19% 19% 30% 25% 22% 30% 30% 27% 17% 14% 6% 3%
1 1 1 1 2 1 5 5 17 6 8 9 5
Interest 0 1 1 0 0 0 2 1 3 6 11 19 24
Depreciation 1 1 1 1 2 2 12 13 19 27 28 34 35
Profit before tax 6 8 11 16 18 25 171 165 152 137 100 -5 -34
Tax % 34% 32% 34% 35% 35% 35% 29% 25% 25% 25% 24% -41%
4 6 7 10 12 16 121 124 115 103 76 -3 -29
EPS in Rs 57.57 79.14 103.86 14.03 15.92 13.97 103.65 51.00 42.20 37.91 27.83 -1.10 -10.49
Dividend Payout % 38% 27% 50% 71% 16% 23% 6% 11% 12% 9% 4% 0%
Compounded Sales Growth
10 Years: 32%
5 Years: 2%
3 Years: 6%
TTM: -20%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -157%
Stock Price CAGR
10 Years: %
5 Years: -13%
3 Years: -33%
1 Year: -24%
Return on Equity
10 Years: 20%
5 Years: 15%
3 Years: 9%
Last Year: -1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.36 0.36 0.36 4 4 6 6 12 27 27 27 28 28
Reserves 15 18 21 19 42 53 254 374 475 576 638 637 626
2 5 8 1 1 1 53 119 150 306 220 216 165
10 14 11 17 23 36 89 125 154 174 220 262 254
Total Liabilities 28 37 40 41 69 96 402 629 806 1,083 1,106 1,142 1,073
10 11 11 12 26 31 130 256 478 509 610 630 625
CWIP 0 0 1 0 0 0 66 129 46 110 70 86 90
Investments 2 2 2 2 7 7 20 34 42 53 53 54 55
15 24 26 26 35 58 187 210 240 410 373 371 303
Total Assets 28 37 40 41 69 96 402 629 806 1,083 1,106 1,142 1,073

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
8 3 6 18 9 18 77 160 115 -11 183 85
-3 -2 -1 -1 -1 -6 -88 -191 -135 -120 -91 -65
-5 -2 -5 -16 -4 -5 2 35 22 146 -109 -23
Net Cash Flow -0 -2 -0 0 4 7 -8 5 1 14 -17 -3

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 71 90 74 71 88 112 73 69 74 97 85 113
Inventory Days 45 94 42 36 97 44 45 47 85 58 69 91
Days Payable 91 81 7 50 130 154 80 97 135 76 100 166
Cash Conversion Cycle 25 103 110 57 55 2 37 20 25 80 54 38
Working Capital Days 5 44 101 66 70 42 55 34 51 90 68 68
ROCE % 37% 43% 43% 61% 52% 48% 91% 41% 27% 18% 12% 1%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
39.01% 39.00% 38.46% 38.43% 38.41% 38.41% 38.37% 37.90% 37.90% 37.77% 37.77% 37.77%
1.98% 1.73% 1.99% 0.68% 0.57% 0.18% 0.30% 0.19% 0.69% 1.14% 1.35% 1.34%
1.90% 1.92% 1.89% 2.13% 1.94% 0.89% 0.88% 0.92% 0.87% 0.43% 0.09% 0.08%
57.11% 57.35% 57.66% 58.78% 59.07% 60.52% 60.43% 60.99% 60.54% 60.65% 60.79% 60.80%
No. of Shareholders 31,98332,79934,53942,49743,10644,30245,84848,59849,05050,46050,02248,189

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls